Resting‐state connectivity predicts levodopa‐induced dyskinesias in Parkinson's disease

Levodopa‐induced dyskinesias are a common side effect of dopaminergic therapy in PD, but their neural correlates remain poorly understood.

[1]  P. Redgrave,et al.  Functional properties of the basal ganglia's re-entrant loop architecture: selection and reinforcement , 2011, Neuroscience.

[2]  P. Calabresi,et al.  Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap , 2010, The Lancet Neurology.

[3]  David Eidelberg,et al.  Metabolic brain networks in translational neurology: Concepts and applications , 2012, Annals of neurology.

[4]  J. Rothwell,et al.  Abnormal bidirectional plasticity-like effects in Parkinson's disease. , 2011, Brain : a journal of neurology.

[5]  W. K. Simmons,et al.  Circular analysis in systems neuroscience: the dangers of double dipping , 2009, Nature Neuroscience.

[6]  E. Bézard,et al.  Basal Ganglia Circuits Underlying the Pathophysiology of Levodopa-Induced Dyskinesia , 2010, Front. Neuroanat..

[7]  L. Grégoire,et al.  Relevance of the MPTP primate model in the study of dyskinesia priming mechanisms. , 2004, Parkinsonism & related disorders.

[8]  Hartwig R. Siebner,et al.  The motor system and its disorders , 2012, NeuroImage.

[9]  C. Kennard,et al.  Functional role of the supplementary and pre-supplementary motor areas , 2008, Nature Reviews Neuroscience.

[10]  S. Eickhoff,et al.  Functional neuroimaging of motor control in parkinson's disease: A meta‐analysis , 2014, Human brain mapping.

[11]  P. Cortelli,et al.  Pharmacodynamic modeling of oral levodopa , 1993, Neurology.

[12]  A. E. Lang,et al.  Breast cancer at site of implanted vagus nerve stimulator , 2007, Neurology.

[13]  A. Dale,et al.  Cortical Surface-Based Analysis II: Inflation, Flattening, and a Surface-Based Coordinate System , 1999, NeuroImage.

[14]  Marianna Amboni,et al.  The modern pre-levodopa era of Parkinson’s disease: insights into motor complications from sub-Saharan Africa , 2014, Brain : a journal of neurology.

[15]  T. Robbins,et al.  A role for mesencephalic dopamine in activation: commentary on Berridge (2006) , 2007, Psychopharmacology.

[16]  Neeraj Kumar,et al.  Levodopa-associated dyskinesia risk among Parkinson disease patients in Olmsted County, Minnesota, 1976-1990. , 2006, Archives of neurology.

[17]  B. Forstmann,et al.  Neurocognitive mechanisms of action control: resisting the call of the Sirens. , 2011, Wiley interdisciplinary reviews. Cognitive science.

[18]  A. Cerasa,et al.  Prefrontal thickening in PD with levodopa-induced dyskinesias: new evidence from cortical thickness measurement. , 2013, Parkinsonism & related disorders.

[19]  M. Cenci,et al.  Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications , 2014, Front. Neurol..

[20]  Francesca Morgante,et al.  Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias. , 2006, Brain : a journal of neurology.

[21]  J. Nutt,et al.  Effect of brief levodopa holidays on the short‐duration response to levodopa , 1994, Neurology.

[22]  A. Aron.  From Reactive to Proactive and Selective Control: Developing a Richer Model for Stopping Inappropriate Responses , 2011, Biological Psychiatry.

[23]  Hartwig R. Siebner,et al.  Abnormal dopaminergic modulation of striato-cortical networks underlies levodopa-induced dyskinesias in humans , 2015, Brain : a journal of neurology.

[24]  Hartwig R. Siebner,et al.  The acute brain response to levodopa heralds dyskinesias in Parkinson disease , 2014, Annals of neurology.

[25]  Joseph Jankovic,et al.  Motor fluctuations and dyskinesias in Parkinson's disease: Clinical manifestations , 2005, Movement disorders : official journal of the Movement Disorder Society.

[26]  P. Cortelli,et al.  Response to a standard oral levodopa test in parkinsonian patients with and without motor fluctuations. , 1990, Clinical neuropharmacology.

[27]  C. Clarke,et al.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[28]  Antonio Cerasa,et al.  A network centred on the inferior frontal cortex is critically involved in levodopa-induced dyskinesias. , 2015, Brain : a journal of neurology.

[29]  M. Fox,et al.  Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging , 2007, Nature Reviews Neuroscience.

[30]  N H Holford,et al.  The response to levodopa in parkinson's disease: Imposing pharmacological law and order , 1996, Annals of neurology.

[31]  J. Rothwell,et al.  Repetitive transcranial magnetic stimulation for levodopa‐induced dyskinesias in Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[32]  Yen F. Tai,et al.  Clinical correlates of levodopa-induced dopamine release in Parkinson disease , 2006, Neurology.

[33]  Nicola Filippini,et al.  Functional connectivity in the basal ganglia network differentiates PD patients from controls , 2014, Neurology.

[34]  Anders M. Dale,et al.  Cortical Surface-Based Analysis I. Segmentation and Surface Reconstruction , 1999, NeuroImage.

[35]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[36]  Antonio Cerasa,et al.  Increased prefrontal volume in PD with levodopa‐induced dyskinesias: A voxel‐based morphometry study , 2011, Movement disorders : official journal of the Movement Disorder Society.

[37]  Ilya M. Veer,et al.  The impact of “physiological correction” on functional connectivity analysis of pharmacological resting state fMRI , 2013, NeuroImage.

[38]  Viviana Versace,et al.  Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinson’s disease , 2006, Clinical Neurophysiology.

[39]  Antonio Cerasa,et al.  Prefrontal alterations in Parkinson's disease with levodopa‐induced dyskinesia during fMRI motor task , 2012, Movement disorders : official journal of the Movement Disorder Society.

[40]  Vesna Sossi,et al.  Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias. , 2004, Brain : a journal of neurology.

[41]  Anders M. Dale,et al.  An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.

[42]  C Caltagirone,et al.  rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease , 2005, Neurology.

[43]  A. Quattrone,et al.  Long‐duration response to levodopa influences the pharmacodynamics of short‐duration response in Parkinson's disease , 1997, Annals of neurology.

[44]  Gilberto Fisone,et al.  Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease , 2015, Progress in Neurobiology.